文献速递关节外科运动医学

肩关节置换术结局的最小临床重要差异存在显著不一致性和变异性:一项系统综述

Substantial Inconsistency and Variability Exists Among Minimum Clinically Important Differences for Shoulder Arthroplasty Outcomes: A Systematic Review.
PubMed 文献 · Clin Orthop Relat Res · 2022-03-17

该系统综述检索2008年12月至2020年12月Embase、PubMed和Ovid/MEDLINE数据库,纳入43篇报告肩关节置换术后患者报告结局测量(PROM)最小临床重要差异(MCID)的文章(16,408例患者),发现各PROM的MCID值范围差异很大,56%的研究使用既往已建立的MCID,44%的研究新计算MCID,结论认为MCID的量化与报告存在显著不一致性和变异性。

要点

  • 各PROM的MCID值范围差异大:ASES为6.3至29.5,SST为1.4至4.0,Constant为-0.3至12.8。
  • 56%(24/43)的研究使用既往已建立的MCID,其中46%(11/24)引用同一项研究。
  • 44%(19/43)的研究新建立MCID,最常用锚定法(37%,7/19),其次为分布法(21%,4/19)。

核心结论

  • 肩关节置换术研究中MCID值的量化与报告存在显著不一致性和变异性。
  • 许多肩关节置换术研究应用既往发表的MCID值且随访范围可变,而非计算特定人群的阈值。
  • 作者认为,使用既往计算的MCID在特定情况下可能可接受,但研究者应选择从与其自身人群尽可能相似的患者群体中计算的锚定法MCID,这优于使用分布法MCID。
  • 作者提出,作为替代方案,作者可考虑使用实质临床获益或患者可接受症状状态来评估肩关节置换术后的结局。

研究设计与样本

  • 系统综述,检索Embase、PubMed和Ovid/MEDLINE数据库2008年12月至2020年12月关于全肩关节置换术和反式全肩关节置换术并报告各种PROM的MCID值的文章。
  • 两名评价者(DAK、MAM)独立筛选符合条件文章并提取数据进行分析;共纳入43篇文章(16,408例患者),平均(范围)随访20个月(0.75至68)。
  • 患者中位(范围)BMI为29.3 kg/m2(28.0至32.2 kg/m2),中位(范围)年龄为68岁(53至84)。
  • 每项研究分为两类:引用既往定义的MCID和使用新计算的MCID;记录每项研究确定MCID的方法及各PROM报告MCID的变异性。
  • 提取每篇文章的患者数、年龄、性别、BMI、随访时长、手术指征和手术类型。

主要发现

  • 共报告112个MCID,涉及17种独特PROM;最常见的PROM为美国肩肘外科医师(ASES)评分(23% [26/112])、简易肩关节测试(SST)(17% [19/112])和Constant评分(15% [17/112])。
  • 各PROM的MCID值范围差异很大:ASES为6.3至29.5,SST为1.4至4.0,Constant为-0.3至12.8。
  • 56%(24/43)的研究使用既往已建立的MCID,其中46%(11/24)引用一项研究。
  • 44%(19/43)的研究建立新MCID,最常用技术为锚定法(37% [7/19]),其次为分布法(21% [4/19])。

关键数值与推荐

  • ASES的MCID值范围为6.3至29.5。
  • SST的MCID值范围为1.4至4.0。
  • Constant评分的MCID值范围为-0.3至12.8。
  • 56%(24/43)的研究使用既往已建立的MCID,其中46%(11/24)引用一项研究。
  • 44%(19/43)的研究建立新MCID,最常用锚定法(37% [7/19]),其次为分布法(21% [4/19])。

临床怎么用

  • 作者认为,使用既往计算的MCID在特定情况下可能可接受,但研究者应选择从与其自身人群尽可能相似的患者群体中计算的锚定法MCID,这优于使用分布法MCID。
  • 作者提出,作为替代方案,作者可考虑使用实质临床获益或患者可接受症状状态来评估肩关节置换术后的结局。
  • 尽管MCID可能提供基于效应量的有用替代方案以取代传统P值,但必须注意使用适合所研究特定患者人群的MCID。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As the value of patient-reported outcomes becomes increasingly recognized, minimum clinically important difference (MCID) thresholds have seen greater use in shoulder arthroplasty. However, MCIDs are unique to certain populations, and variation in the modes of calculation in this field may be of concern. With the growing utilization of MCIDs within the field and value-based care models, a detailed appraisal of the appropriateness of MCID use in the literature is necessary and has not been systematically reviewed. QUESTIONS/PURPOSES: We performed a systematic review of MCID quantification in existing studies on shoulder arthroplasty to answer the following questions: (1) What is the range of values reported for the MCID in commonly used shoulder arthroplasty patient-reported outcome measures (PROMs)? (2) What percentage of studies use previously existing MCIDs versus calculating a new MCID? (3) What techniques for calculating the MCID were used in studies where a new MCID was calculated? METHODS: The Embase, PubMed, and Ovid/MEDLINE databases were queried from December 2008 through December 2020 for total shoulder arthroplasty and reverse total shoulder arthroplasty articles reporting an MCID value for various PROMs. Two reviewers (DAK, MAM) independently screened articles for eligibility, specifically identifying articles that reported MCID values for PROMs after shoulder arthroplasty, and extracted data for analysis. Each study was classified into two categories: those referencing a previously defined MCID and those using a newly calculated MCID. Methods for determining the MCID for each study and the variability of reported MCIDs for each PROM were recorded. The number of patients, age, gender, BMI, length of follow-up, surgical indications, and surgical type were extracted for each article. Forty-three articles (16,408 patients) with a mean (range) follow-up of 20 months (0.75 to 68) met the inclusion criteria. The median (range) BMI of patients was 29.3 kg/m2 (28.0 to 32.2 kg/m2), and the median (range) age was 68 years (53 to 84). There were 17 unique PROMs with MCID values. Of the 112 MCIDs reported, the most common PROMs with MCIDs were the American Shoulder and Elbow Surgeons (ASES) (23% [26 of 112]), the Simple Shoulder Test (SST) (17% [19 of 112]), and the Constant (15% [17 of 112]). RESULTS: The ranges of MCID values for each PROM varied widely (ASES: 6.3 to 29.5; SST: 1.4 to 4.0; Constant: -0.3 to 12.8). Fifty-six percent (24 of 43) of studies used previously established MCIDs, with 46% (11 of 24) citing one study. Forty-four percent (19 of 43) of studies established new MCIDs, and the most common technique was anchor-based (37% [7 of 19]), followed by distribution (21% [4 of 19]). CONCLUSION: There is substantial inconsistency and variability in the quantification and reporting of MCID values in shoulder arthroplasty studies. Many shoulder arthroplasty studies apply previously published MCID values with variable ranges of follow-up rather than calculating population-specific thresholds. The use of previously calculated MCIDs may be acceptable in specific situations; however, investigators should select an anchor-based MCID calculated from a patient population as similar as possible to their own. This practice is preferable to the use of distribution-approach MCID methods. Alternatively, authors may consider using substantial clinical benefit or patient-acceptable symptom state to assess outcomes after shoulder arthroplasty. CLINICAL RELEVANCE: Although MCIDs may provide a useful effect-size based alternative to the traditional p value, care must be taken to use an MCID that is appropriate for the particular patient population being studied.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Kolin DA, Moverman MA, Pagani NR, et al. Substantial Inconsistency and Variability Exists Among Minimum Clinically Important Differences for Shoulder Arthroplasty Outcomes: A Systematic Review. Clin Orthop Relat Res. 2022. PMID: 35302970. doi:10.1097/CORR.0000000000002164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。